HGERS
QNCX icon

Householder Group Estate & Retirement Specialist’s Quince Therapeutics QNCX Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$112 – 1288
2023
Q3 		$112 Buy
+1
New +$261 ﹤0.01% 1256
2023
Q1 		$0 Hold
1
– – ﹤0.01% 1293
2022
Q4 		$0 Hold
1
– – ﹤0.01% 916
2022
Q3 		$0 Buy
+1
New +$381 ﹤0.01% 1179

Other funds holding QNCX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's QNCX Position: Q4 2023 in Review

Householder Group Estate & Retirement Specialist sold out of Quince Therapeutics (QNCX) in Q4 2023, closing a stake of 1 share — an estimated $112 sold.

Householder Group Estate & Retirement Specialist first reported a position in QNCX in Q3 2022 and held it in 4 quarters. The position peaked at $112 in Q3 2023. 42 funds tracked by Wall St. Rank hold QNCX as of Q4 2023.

  • Householder Group Estate & Retirement Specialist reported no remaining Quince Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 1 Quince Therapeutics share in Q4 2023, an estimated $112.
  • Householder Group Estate & Retirement Specialist first reported a position in Quince Therapeutics in Q3 2022 and held it in 4 quarters.
  • Householder Group Estate & Retirement Specialist's Quince Therapeutics position peaked at $112 in Q3 2023.
  • 42 funds tracked by Wall St. Rank held Quince Therapeutics as of Q4 2023.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2023, filed 23 Jan 2024.